EP0244088A3 - 1-phenyl-3-benzazepine compounds and medicaments containing these compounds for treating gastrointestinal motility disorders - Google Patents

1-phenyl-3-benzazepine compounds and medicaments containing these compounds for treating gastrointestinal motility disorders Download PDF

Info

Publication number
EP0244088A3
EP0244088A3 EP87302724A EP87302724A EP0244088A3 EP 0244088 A3 EP0244088 A3 EP 0244088A3 EP 87302724 A EP87302724 A EP 87302724A EP 87302724 A EP87302724 A EP 87302724A EP 0244088 A3 EP0244088 A3 EP 0244088A3
Authority
EP
European Patent Office
Prior art keywords
compounds
c6alkyl
hydrogen
gastrointestinal motility
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP87302724A
Other languages
German (de)
French (fr)
Other versions
EP0244088A2 (en
Inventor
William Edward Bondinell
Herbert Stowell Ormsbee Iii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP0244088A2 publication Critical patent/EP0244088A2/en
Publication of EP0244088A3 publication Critical patent/EP0244088A3/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compounds of the formula (I) and pharmaceutically acceptable acid addition salts thereof for use in treating gastrointestinal motility disorders are described wherein R¹ is hydrogen. C₁-C₆alkyl or C₃-C₅alkenyl; R² is hydrogen, hydroxy, C₁-C₆alkoxy, halogen, trifluoromethyl, C₁-C₆alkyl, SOn(C₁-C₆)alkyl, SOnCF₃, SOnphenyl or SO₂NR⁵R⁶; R³ is hydrogen, halogen, CF₃, C₁-C₆alkyl or R⁷O; R⁴ is hydroxy, C₁-C₆alkoxy, C₁-C₆alkyl, SOn(C₁-C₆) alkyl, NH₂, NO₂, halogen, trifluoromethyl, C₁-C₆alkylsulfonamido, C₁-C₆alkanoylamino, hydroxymethyl or C₁-C₆alkoxymethyl, except that when R³ is hydroxy in the 7-position and R¹ is hydrogen or when R³ is hydroxy in the 8-position and R¹ is methyl, R⁴ may be halogen or trifluoromethyl only if it is in the 6- or 9-position; n is 0, l or 2; R⁵ and R⁶ are hydrogen or C₁-C₆alkyl; and R⁷ is hydrogen, C₁-C₆alkyl or C₁-C₆alkanoyl.
Pharmaceutical compositions containing them and their use in the manufacture of medicaments for treating gastrointestinal motility disorders are described.
EP87302724A 1986-04-03 1987-03-30 1-phenyl-3-benzazepine compounds and medicaments containing these compounds for treating gastrointestinal motility disorders Withdrawn EP0244088A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84797686A 1986-04-03 1986-04-03
US847976 1986-04-03

Publications (2)

Publication Number Publication Date
EP0244088A2 EP0244088A2 (en) 1987-11-04
EP0244088A3 true EP0244088A3 (en) 1989-03-15

Family

ID=25302008

Family Applications (1)

Application Number Title Priority Date Filing Date
EP87302724A Withdrawn EP0244088A3 (en) 1986-04-03 1987-03-30 1-phenyl-3-benzazepine compounds and medicaments containing these compounds for treating gastrointestinal motility disorders

Country Status (6)

Country Link
EP (1) EP0244088A3 (en)
JP (1) JPS62238271A (en)
AU (1) AU7098087A (en)
DK (1) DK173387A (en)
PT (1) PT84622B (en)
ZA (1) ZA872393B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK325188D0 (en) * 1988-06-15 1988-06-15 Novo Industri As BENZAZEPINE DERIVATIVES UNKNOWN
GB2271566A (en) * 1992-10-14 1994-04-20 Merck & Co Inc HIV integrase inhibitors
CN1823059A (en) * 2003-05-22 2006-08-23 先灵公司 Selective D1/dD receptor antagonists for the treatment of obesity and CNS disorders
CN116983314B (en) * 2023-09-28 2024-02-09 首都医科大学附属北京中医医院 Application of D1-like receptor agonist in preparation of gastric motility enhancing drugs

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0027348A1 (en) * 1979-10-11 1981-04-22 Smithkline Beckman Corporation 7,8-Dihydroxy-1-(sulfamylphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine derivatives, a process for their preparation and compositions containing them
EP0033632A2 (en) * 1980-01-31 1981-08-12 Smithkline Beckman Corporation 7,8-Amino, hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines, process for their preparation and pharmaceutical compositions containing them
WO1985000808A1 (en) * 1983-08-12 1985-02-28 Schering Corp. Benzazepine derivatives, pharmaceutical compositions containing them and processes for the preparation of such compounds and compositions
EP0230755A1 (en) * 1985-12-20 1987-08-05 Smithkline Beecham Corporation 1-Phenyl-3-benzazepines

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0027348A1 (en) * 1979-10-11 1981-04-22 Smithkline Beckman Corporation 7,8-Dihydroxy-1-(sulfamylphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine derivatives, a process for their preparation and compositions containing them
EP0033632A2 (en) * 1980-01-31 1981-08-12 Smithkline Beckman Corporation 7,8-Amino, hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines, process for their preparation and pharmaceutical compositions containing them
WO1985000808A1 (en) * 1983-08-12 1985-02-28 Schering Corp. Benzazepine derivatives, pharmaceutical compositions containing them and processes for the preparation of such compounds and compositions
EP0230755A1 (en) * 1985-12-20 1987-08-05 Smithkline Beecham Corporation 1-Phenyl-3-benzazepines

Also Published As

Publication number Publication date
PT84622A (en) 1987-05-01
DK173387A (en) 1987-10-04
JPS62238271A (en) 1987-10-19
EP0244088A2 (en) 1987-11-04
AU7098087A (en) 1987-10-08
ZA872393B (en) 1988-02-24
PT84622B (en) 1989-05-26
DK173387D0 (en) 1987-04-03

Similar Documents

Publication Publication Date Title
EP0285287A3 (en) 3-benzazepine compounds for use in treating gastrointestinal motility disorders
ATE37179T1 (en) DIHYDROPYRIDAZINONES.
ES525122A0 (en) PROCEDURE FOR PREPARING PIRIDINE DERIVATIVES
DK0585328T3 (en) Substituted 3-aminoquinuclidines
DK224286D0 (en) 2 ', 3'-dideoxy nucleosides
EP0251784A3 (en) Naphthalenylsulfonylimidazolidinediones and their thioxo analogs
EP0244088A3 (en) 1-phenyl-3-benzazepine compounds and medicaments containing these compounds for treating gastrointestinal motility disorders
IT1197516B (en) THEOFILLINMETYLANIC AND THEOFILLINMETYLDITIAN DERIVATIVES PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM
EP0207497A3 (en) Quinolonecarboxylic acid derivative and process for its preparation
SE8105689L (en) THERAPEUTIC AGENTS
EP0233745A3 (en) Chemical compounds
ATE53385T1 (en) SULFINYL AND SULFONYL SUBSTITUTED 3BENZAZEPINES.
ES554830A0 (en) PROCEDURE FOR PREPARING 1,3-OXATIAN DERIVATIVES
EP0341837A3 (en) Glutamic acid derivatives
DE3853958D1 (en) Substituted pyridine compounds, their preparation and pharmaceutical compositions containing them.
EP0221541A3 (en) Quinolonecarboxylic acid derivatives and their preparation
MX10256A (en) PROCEDURE FOR PREPARING NEW 3-PHENYL-7H-TIAZOLO (3, 2-B) (1, 2, 4) TRIAZIN-7-ONAS.
DK416084A (en) FLAVENE AND THIOFLAVENER DERIVATIVES AND SALTS THEREOF, AND THEIR PREPARATION AND USE
ES8202811A1 (en) 1,4-Benzodioxines, processes for their preparation and their use in therapy.
JPS5346971A (en) 2-halogenomethylindole derivatives and their preparation
CA2322790A1 (en) Granulatimide derivatives for use in cancer treatment

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19870406

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH DE ES FR GB GR IT LI LU NL SE

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH DE ES FR GB GR IT LI LU NL SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19911003

RIN1 Information on inventor provided before grant (corrected)

Inventor name: BONDINELL, WILLIAM EDWARD

Inventor name: ORMSBEE III, HERBERT STOWELL